 |
recombinant human biglycan |
|---|---|
| Trade Name | |
| Orphan Indication | Duchenne muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-13 00:00:00 |
| Sponsor | Tivorsan Pharmaceuticals, Inc.;3 Davol Square, A340;Providence, Rhode Island, 02903 |
| |
recombinant human biglycan |
|---|---|
| Trade Name | |
| Orphan Indication | Duchenne muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-13 00:00:00 |
| Sponsor | Tivorsan Pharmaceuticals, Inc.;3 Davol Square, A340;Providence, Rhode Island, 02903 |